Vynca Taps Palliative Care Leader to Scale Tech-Driven Illness Care

SAN FRANCISCO, CA – February 10, 2026 – Health technology firm Vynca has appointed Dr. Jill Schwartz-Chevlin, a veteran leader in palliative medicine, as its new Chief Medical Officer. The move signals a significant push to scale its tech-enabled palliative care model, combining Dr. Schwartz-Chevlin’s formidable track record in value-based care with Vynca’s predictive analytics platform to redefine how patients with serious illnesses are supported in their homes and communities.

In her new role, Dr. Schwartz-Chevlin will spearhead Vynca’s clinical strategy. Her appointment comes at a critical time, as an aging population and the rising prevalence of chronic conditions put increasing pressure on the U.S. healthcare system to find more effective and efficient ways to care for its most complex patients.

A Proven Leader in Value-Based Palliative Care

Dr. Schwartz-Chevlin brings to Vynca more than two decades of experience building and scaling home-based care programs that have delivered impressive clinical and financial results. Her career has been defined by her ability to successfully implement palliative care models that improve patient quality of life while significantly reducing costly and often avoidable hospitalizations.

Most recently, as Chief Medical Officer for Serious Illness at WellBe Senior Medical, she oversaw palliative care strategy for over 50,000 patients, contributing to a 40% reduction in hospital utilization. Before that, as Senior Medical Officer at Landmark Health (now part of Optum), she developed and expanded national palliative care programs covering more than 60,000 individuals across over 20 states, achieving a notable 26% reduction in medical costs for the highest-risk populations.

“Access to high-quality palliative care in the community across the country for patients not in hospice care is very limited, despite its proven, positive impact on quality of life and the cost of care,” said Darren Schulte, MD, MPP, CEO of Vynca. “Jill’s rare depth across clinical leadership, payer collaboration, and operational execution will strengthen Vynca’s ability to deliver earlier, more effective interventions that benefit patients, providers, and health plans alike.”

Her experience is not just in large-scale operations. Dr. Schwartz-Chevlin’s career began on the front lines, where she founded and led a profitable home-based primary and palliative care practice and served as the founding Medical Director for a hospice, giving her a ground-level understanding of the challenges patients and providers face.

Beyond Hospice: A High-Tech, High-Touch Approach

The core of Vynca's strategy lies in addressing the vast, underserved population of individuals living with serious illnesses who are not yet eligible for, or in need of, hospice. Palliative care is often misunderstood as being solely for end-of-life, but its principles—symptom management, care coordination, and aligning treatment with patient goals—are beneficial much earlier in a disease trajectory. Vynca’s model is designed to intervene at this crucial stage.

The company leverages a hybrid approach that combines “high-touch” interdisciplinary care teams—including physicians, nurses, social workers, and chaplains who conduct in-home and telehealth visits—with a sophisticated “high-tech” platform. This proprietary technology is the engine of Vynca’s proactive model. Using artificial intelligence and machine learning, the platform analyzes data from electronic health records, remote monitoring devices, and patient-reported information to identify individuals with unmet needs and predict who is at risk of a crisis, often days or weeks in advance.

This predictive capability allows Vynca’s clinical teams to move from a reactive to a proactive stance, intervening before a patient’s symptoms escalate into an emergency. The system can trigger automated workflows, for instance, scheduling a clinician visit within 24 hours when a patient's risk score rises, thereby preventing a trip to the emergency department.

“Vynca’s approach—combining predictive insights with interdisciplinary, patient-centered care—creates an opportunity to reach people earlier, align care with what matters most to them, and reduce unnecessary suffering and utilization,” Dr. Schwartz-Chevlin stated. “I’m excited to advance that mission alongside health plans and care partners nationwide.”

The Tangible ROI of Compassionate Care

For health plans and hospital systems struggling with the high costs associated with complex patient populations, Vynca’s model presents a compelling value proposition. The company reports that its approach has demonstrated a 43% reduction in emergency department visits and a 52% reduction in hospital admissions. These outcomes translate into substantial financial savings, estimated between $1,700 and $3,400 per patient per month.

These savings are generated by providing the right level of care in the right setting. By managing symptoms effectively at home, coordinating with a patient’s various specialists, and focusing on advance care planning, the model helps avoid the cycle of crisis and costly hospitalization that often characterizes the experience of serious illness. Vynca also operates the largest advance care planning network in the U.S., ensuring patient wishes are documented and accessible across care settings, which further prevents unwanted and expensive interventions.

The financial argument is strengthened by Dr. Schwartz-Chevlin's history of delivering a strong return on investment in similar programs. Her success in reducing medical costs and hospitalizations at previous organizations provides a powerful proof point for health plans considering partnerships with Vynca.

Meeting a Growing Need in a Shifting Landscape

The appointment and Vynca’s expansion efforts are occurring within a broader context of demographic and policy shifts. With the U.S. population aging, the number of people living with multiple chronic and serious conditions is set to grow, placing an unsustainable burden on the current healthcare infrastructure. In response, payers and policymakers, including the Centers for Medicare & Medicaid Services (CMS), are increasingly championing value-based care models that reward outcomes over volume.

Programs that can demonstrate an ability to improve patient well-being while controlling costs are in high demand. Vynca’s tech-enabled, community-based palliative care model is positioned to meet this demand head-on. The company's continued investment in top-tier clinical leadership, underscored by Dr. Schwartz-Chevlin's appointment, solidifies its strategy to become a key partner for health plans and providers seeking scalable solutions for one of healthcare’s most pressing challenges.